Chimerix Board Changes: Machado Resigns, Kozin AppointedTipRanks Financial Blog • about 1 month ago
The latest announcement is out from Chimerix (CMRX). Patrick Machado has announced his resignation from the Board of Directors of Chimerix, Inc., e...
Share to Feed
Veteran Industry Executive Brings More Than 35 Years of Corporate Strategy ExperienceDURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose...
StockNews.com upgraded shares of Chimerix (NASDAQ:CMRX Free Report) from a sell rating to a hold rating in a research report released on Monday.
Other research analysts also recently issued...
Chimerix ( NASDAQ:CMRX ) Full Year 2023 Results Key Financial Results Net loss: US$82.1m (down by 148% from US$172.2m...
Chimerix: Tackling A Strong Unmet Need With Promising Data...
ONC201 ACTION Study Progressing; Reiterate Interim OS Data Expected in 2025, Final OS Data Expected in 2026 Phase 2 ONC201 Data Published in Peer-Reviewed Journal of Clinical Oncology $204...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
DURHAM, N.C., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients...
DURHAM, N.C., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients...